Industry insiders weigh in on the growing pains of Oregon's regulated psilocybin program which has seen concerns raised about licensing fees and some service centers close.

Oregon Health & Science University has been awarded a $3.3 million grant from the National Institute on Drug Abuse to study outcomes from legal, state-regulated psilocybin services in real-world community settings.

Misleading headlines around New Jersey’s psilocybin pilot program reveal how misinformation and weak media literacy are distorting psychedelic policy debates nationwide.

Without deliberate policy solutions, state-based programs risk remaining narrow, unaffordable, and politically fragile. But if we can solve for affordability, the implications extend far beyond psychedelics.

Over the coming months, we will be sharing a short series on Oregon’s lessons, national trends, and how states can build the first wave of affordable, state-funded access programs that meet people where they are.